Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shigeo Horie

Showing results (1-10 of 346) with videos related to

Pageof 35
Sort By:
Kidney International|October 23, 2017
Sensing the texture of imaging, a new biomarker of polycystic kidney diseaseShigeo Horie
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 7, 2005
[Molecular targeting drug designing for polycystic kidney]Shigeo Horie
Clinical Calcium|February 2, 2010
[Bone and Men's Health. Measurement of salivary testosterone]Shigeo Horie
Nihon Jinzo Gakkai Shi|March 5, 2011
[Autosomal dominant polycystic kidney disease]Shigeo Horie
Clinical Calcium|March 26, 2010
[New findings on testosterone and bone]Shigeo Horie
Korean Journal of Urology|November 9, 2012
Chemoprevention of prostate cancer: soy isoflavones and curcuminShigeo Horie
International Journal of Urology : Official Journal of the Japanese Urological Association|August 24, 2010
Editorial comment to Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesisShigeo Horie
Kidney International|July 1, 2015
Will introduction of tolvaptan change clinical practice in autosomal dominant polycystic kidney disease?Shigeo Horie
Nihon Jinzo Gakkai Shi|March 5, 2015
[New strategy for the treatment of autosomal dominant polycystic kidney disease]Shigeo Horie
Clinical and Experimental Nephrology|December 20, 2005
ADPKD: molecular characterization and quest for treatmentShigeo Horie
Pageof 35

Showing results (1-10 of 346) with videos related to

Sort By:
Pageof 35
Kidney International|October 23, 2017
Sensing the texture of imaging, a new biomarker of polycystic kidney diseaseShigeo Horie
Nihon Naika Gakkai Zasshi. the Journal of the Japanese Society of Internal Medicine|July 7, 2005
[Molecular targeting drug designing for polycystic kidney]Shigeo Horie
Clinical Calcium|February 2, 2010
[Bone and Men's Health. Measurement of salivary testosterone]Shigeo Horie
Nihon Jinzo Gakkai Shi|March 5, 2011
[Autosomal dominant polycystic kidney disease]Shigeo Horie
Clinical Calcium|March 26, 2010
[New findings on testosterone and bone]Shigeo Horie
Korean Journal of Urology|November 9, 2012
Chemoprevention of prostate cancer: soy isoflavones and curcuminShigeo Horie
International Journal of Urology : Official Journal of the Japanese Urological Association|August 24, 2010
Editorial comment to Inverse expression of estrogen receptor-beta and nuclear factor-kappaB in urinary bladder carcinogenesisShigeo Horie
Kidney International|July 1, 2015
Will introduction of tolvaptan change clinical practice in autosomal dominant polycystic kidney disease?Shigeo Horie
Nihon Jinzo Gakkai Shi|March 5, 2015
[New strategy for the treatment of autosomal dominant polycystic kidney disease]Shigeo Horie
Clinical and Experimental Nephrology|December 20, 2005
ADPKD: molecular characterization and quest for treatmentShigeo Horie
Pageof 35